Fluticasone furoate: CAPTAIN of fluticasones in type 2 inflammatory asthma by Couillard, S, Pavord, ID

Anti-IL-4/IL-13 for the treatment of asthma: the story so far by Moran, A, Pavord, ID

The Lancet COPD Commission: broader questions remain by Petousi, N, Pavord, ID, Couillard, S

Associations between blood eosinophils and decline in lung function among adults with and without asthma by Hancox, RJ, Pavord, ID, Sears, MR

Type 2 inflammation and biological therapies in asthma: targeted medicine taking flight by Howell, I, Howell, A, Pavord, ID

Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease by Petousi, N, Pavord, ID, Kent, BD

How I do it: workup of severe asthma by Couillard, S, Jackson, DJ, Wechsler, ME, Pavord, ID

Exacerbations of COPD by Pavord ID, Jones PW, Burgel PR, Rabe KF

Get full text

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD by Russell REK, Beer S, Pavord ID, Pullinger R, Bafadhel M

Get full text

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial by Siva R, Bafadhel M, Monteiro W, Brightling CE, Pavord ID

Get full text

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids by Siddiqui SH, Pavord ID, Barnes NC, Guasconi A, Lettis S, Pascoe S, Petruzzelli S

Get full text

Using fractional exhaled nitric oxide to guide step down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis by Wang, K, Verbakel, JY, Oke, J, Brewin, J, Roberts, N, Pavord, ID

Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis by Oliver, ME, Poole, S, Borg, C, Connolly, C, Pavord, ID, Hinks, TSC, Couillard, S

A proof-of-concept scale to predict asthma attacks: the OxfoRd Asthma attaCk risk ScaLE (ORACLE) by Couillard, S, Laugerud, A, Jabeen, M, Ramakrishnan, S, Melhorn, J, Hinks, TSC, Pavord, ID

Multidimensional assessment of severe asthma: A systematic review and meta‐analysis by Clark, VL, Gibson, PG, Genn, G, Hiles, SA, Pavord, ID, McDonald, VM

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo by Howell, I, Bratton, DJ, Hynes, G, Yancey, SW, Heaney, LG, Pavord, ID, Shrimanker, R

The use of benralizumab in the treatment of near fatal asthma: a new approach by Ramakrishnan, S, Camp, JR, Vijayakumar, B, Hardinge, FM, Downs, ML, Russell, REK, Pavord, ID, Bafadhel, M

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma by Moran, AM, Ramakrishnan, S, Borg, CA, Connolly, CM, Couillard, S, Mwasuku, CM, Pavord, ID, Hinks, T, Lehtimaki, L

Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids while on monoclonal antibody therapy: protocol for a prospective observational study (BOOST) by Howell, I, Mahdi, M, Bafadhel, M, Hinks, TSC, Ramakrishnan, S, Melhorn, J, Jabeen, M, Pavord, ID

Epithelial immune activation and intracellular invasion by non-typeable Haemophilus influenzae by Brown, MA, Morgan, SB, Donachie, GE, Horton, KL, Pavord, ID, Arancibia-Cárcamo, CV, Hinks, TSC